Jacobs Levy Equity Management Inc. Sells 248,829 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Jacobs Levy Equity Management Inc. lessened its holdings in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 76.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 77,678 shares of the company’s stock after selling 248,829 shares during the period. Jacobs Levy Equity Management Inc.’s holdings in Ryan Specialty were worth $5,157,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the business. Signaturefd LLC raised its holdings in Ryan Specialty by 12.3% during the 3rd quarter. Signaturefd LLC now owns 1,347 shares of the company’s stock worth $89,000 after buying an additional 148 shares during the period. UMB Bank n.a. increased its position in shares of Ryan Specialty by 5.2% during the third quarter. UMB Bank n.a. now owns 5,224 shares of the company’s stock worth $347,000 after acquiring an additional 256 shares in the last quarter. Loomis Sayles & Co. L P raised its holdings in shares of Ryan Specialty by 26.3% during the third quarter. Loomis Sayles & Co. L P now owns 1,373 shares of the company’s stock worth $91,000 after acquiring an additional 286 shares during the period. GAMMA Investing LLC lifted its position in Ryan Specialty by 96.4% in the 2nd quarter. GAMMA Investing LLC now owns 605 shares of the company’s stock valued at $35,000 after acquiring an additional 297 shares in the last quarter. Finally, Hollencrest Capital Management acquired a new position in Ryan Specialty in the 3rd quarter worth $25,000. 84.82% of the stock is currently owned by institutional investors and hedge funds.

Ryan Specialty Stock Performance

Shares of RYAN opened at $72.53 on Friday. The company has a market cap of $18.99 billion, a PE ratio of 94.19, a price-to-earnings-growth ratio of 1.68 and a beta of 0.67. The firm has a 50-day moving average of $70.86 and a 200-day moving average of $63.84. Ryan Specialty Holdings, Inc. has a one year low of $41.49 and a one year high of $75.97. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.01 and a quick ratio of 1.01.

Ryan Specialty (NYSE:RYAN) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, hitting analysts’ consensus estimates of $0.41. The business had revenue of $604.69 million during the quarter, compared to analysts’ expectations of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. Ryan Specialty’s quarterly revenue was up 20.5% on a year-over-year basis. During the same quarter last year, the company posted $0.32 earnings per share. As a group, equities analysts forecast that Ryan Specialty Holdings, Inc. will post 1.8 earnings per share for the current year.

Ryan Specialty Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were paid a $0.11 dividend. This represents a $0.44 dividend on an annualized basis and a yield of 0.61%. The ex-dividend date was Tuesday, November 12th. Ryan Specialty’s dividend payout ratio (DPR) is presently 57.14%.

Analysts Set New Price Targets

Several research firms have issued reports on RYAN. Barclays lifted their price target on Ryan Specialty from $76.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, November 21st. BMO Capital Markets upgraded Ryan Specialty from a “market perform” rating to an “outperform” rating and boosted their target price for the company from $65.00 to $75.00 in a research note on Tuesday, September 24th. The Goldman Sachs Group raised their price target on shares of Ryan Specialty from $64.00 to $72.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 9th. Bank of America boosted their price objective on shares of Ryan Specialty from $75.00 to $84.00 and gave the stock a “buy” rating in a research report on Thursday, October 10th. Finally, Wells Fargo & Company raised their target price on shares of Ryan Specialty from $63.00 to $70.00 and gave the company an “equal weight” rating in a research report on Thursday, October 10th. One analyst has rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the company. According to MarketBeat.com, Ryan Specialty currently has an average rating of “Hold” and an average target price of $73.50.

Insider Buying and Selling at Ryan Specialty

In other news, EVP Mark Stephen Katz sold 14,790 shares of the stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the transaction, the executive vice president now owns 12,386 shares in the company, valued at approximately $884,236.54. This trade represents a 54.42 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director David P. Bolger sold 7,055 shares of Ryan Specialty stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $70.88, for a total value of $500,058.40. Following the sale, the director now directly owns 78,149 shares of the company’s stock, valued at approximately $5,539,201.12. The trade was a 8.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 11.10% of the company’s stock.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.